Journal of the Economics of Ageing, published by ELSEVIER, is a leading international journal dedicated to exploring the economic aspects of ageing in the global context. With an ISSN of 2212-828X, it aims to provide a platform for innovative research that addresses the socio-economic implications of demographic shifts, particularly those related to life-span and life-course studies. Since its inception in 2013, the journal has rapidly established itself within the Q2 category in both the Economics and Econometrics and Life-span and Life-course Studies fields, reflecting its significant contribution to these disciplines. Based in the Netherlands, this journal is indexed with a respectable percentile ranking, such as 69th in Life-span and Life-course Studies, confirming its value to researchers and professionals alike. Committed to disseminating impactful research, the Journal of the Economics of Ageing ultimately seeks to influence policy and funding decisions that shape the future of ageing populations.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

HEALTH SERVICES RESEARCH, published by Wiley, is a premier journal focused on advancing the field of health policy and services research. With an ISSN of 0017-9124 and an impressive E-ISSN of 1475-6773, this esteemed publication has been at the forefront of health services inquiry since its inception in 1966. Recognized as a Q1 journal in Health Policy for 2023, it ranks #80 out of 310 in Scopus, placing it in the 74th percentile, underlining its significant influence in the field. The journal caters to a global audience of researchers, practitioners, and students by providing a platform for rigorous empirical studies and critical reviews that aim to improve health care delivery and policy outcomes. Although it does not offer open access, the comprehensive articles and insights published within its pages are essential for anyone seeking to understand and influence health systems. With its convergence towards the year 2024, HEALTH SERVICES RESEARCH continues to be a vital resource for those dedicated to enhancing healthcare effectiveness and accessibility.

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

The European Journal of Health Economics, published by SPRINGER, is a premier interdisciplinary journal dedicated to advancing research in the intersection of health policy and economic theory. With an impressive impact factor and consistently ranked in the Q1 category in both Economics and Health Policy (2023), this journal serves as a vital platform for disseminating innovative research findings and practical insights relevant to today's healthcare challenges. Covering a broad spectrum of topics, from health care financing and economic evaluation to policy analysis, the journal aims to foster dialogue among academics, policymakers, and practitioners alike. Published continuously from 2002 to 2024, the European Journal of Health Economics holds its rank within the top 12% of Economics and Finance journals and the top 16% in Medicine. Researchers and students looking to stay abreast of the latest trends and methodologies in health economics will find this journal an invaluable resource.

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!

Welcome to the American Economic Journal - Applied Economics, a premier publication in the field of applied economics that strives to provide scholars and practitioners with cutting-edge research and insights. Published by the American Economic Association, this journal ranks in the top quartile (Q1) of Economics, Econometrics, and Finance categories as of 2023, reflecting its significant impact and relevance in the field. With a notable Scopus ranking of #5 out of 288 in General Economics and a distinguished percentile of 98th, this journal serves as a vital resource for advancing knowledge in economic theory and its application to real-world issues. Although not open access, it remains accessible to a broad audience, and welcomes submissions that explore innovative methodologies and empirical analyses that bridge theory and practice. Spanning from 2009 to 2024, the journal not only supports rigorous academic discourse but also plays a crucial role in shaping the discourse around effective economic policy. We invite researchers, professionals, and students in the field to engage with the high-quality work published within these pages.